Thesis (Ph.D.)--University of Washington, 2015Abstract 1: An estimated 1.2 million people in the United States are living with the human immunodeficiency virus (HIV), as reported by the Center for Disease Control (CDC). Because mutations constantly occur throughout the HIV genome, a cure has yet to be found to eradicate the virus. Instead, treatment with Highly Active Antiretroviral Therapy (HAART) effectively postpones the progression of HIV to AIDS (Acquired Immune Deficiency Syndrome) by eliminating most circulating viruses through drugs that target reverse transcription, integration, or HIV-1 fusion and entry. While this combination therapy has been shown to be very effective, it is unable to target viral reservoirs in patients, allowin...
AbstractTreatment of HIV has long faced the challenge of high mutation rates leading to rapid develo...
Thesis (Ph.D.)--University of Washington, 2015One very challenging aspect of developing HIV vaccines...
Thesis (Ph.D.)--University of Washington, 2015One very challenging aspect of developing HIV vaccines...
Thesis (Ph.D.)--University of Washington, 2015Abstract 1: An estimated 1.2 million people in the Uni...
Great strides have been made toward understanding and fighting the Human Immunodeficiency Virus-1 in...
University of Minnesota Ph.D. dissertation.July 2018. Major: Pharmacology. Advisor: Reuben Harris. 1...
Includes bibliographical references.Great strides have been made toward understanding and fighting t...
Worldwide, it is estimated that 37 million people are living with HIV/AIDS. Only 35 years ago, the ...
There is currently no safe, scalable cure for HIV-1 infection due to the persistence of a latent vir...
Abstract Potent anti-retroviral therapy has transformed HIV-1 infection into a chronic manageable di...
Worldwide, it is estimated that 37 million people are living with HIV/AIDS. Only 35 years ago, the ...
© 2018 Bentham Science PublishersBackground: Few HIV-1fusion and replication inhibitors were develop...
Abstract Potent anti-retroviral therapy has transformed HIV-1 infection into a chronic manageable di...
Thesis: Ph. D., Massachusetts Institute of Technology, Department of Chemistry, 2019Cataloged from P...
Oral presentations Background: We selected peptide ligands for the HIV-1 packaging signal PSI by scr...
AbstractTreatment of HIV has long faced the challenge of high mutation rates leading to rapid develo...
Thesis (Ph.D.)--University of Washington, 2015One very challenging aspect of developing HIV vaccines...
Thesis (Ph.D.)--University of Washington, 2015One very challenging aspect of developing HIV vaccines...
Thesis (Ph.D.)--University of Washington, 2015Abstract 1: An estimated 1.2 million people in the Uni...
Great strides have been made toward understanding and fighting the Human Immunodeficiency Virus-1 in...
University of Minnesota Ph.D. dissertation.July 2018. Major: Pharmacology. Advisor: Reuben Harris. 1...
Includes bibliographical references.Great strides have been made toward understanding and fighting t...
Worldwide, it is estimated that 37 million people are living with HIV/AIDS. Only 35 years ago, the ...
There is currently no safe, scalable cure for HIV-1 infection due to the persistence of a latent vir...
Abstract Potent anti-retroviral therapy has transformed HIV-1 infection into a chronic manageable di...
Worldwide, it is estimated that 37 million people are living with HIV/AIDS. Only 35 years ago, the ...
© 2018 Bentham Science PublishersBackground: Few HIV-1fusion and replication inhibitors were develop...
Abstract Potent anti-retroviral therapy has transformed HIV-1 infection into a chronic manageable di...
Thesis: Ph. D., Massachusetts Institute of Technology, Department of Chemistry, 2019Cataloged from P...
Oral presentations Background: We selected peptide ligands for the HIV-1 packaging signal PSI by scr...
AbstractTreatment of HIV has long faced the challenge of high mutation rates leading to rapid develo...
Thesis (Ph.D.)--University of Washington, 2015One very challenging aspect of developing HIV vaccines...
Thesis (Ph.D.)--University of Washington, 2015One very challenging aspect of developing HIV vaccines...